Can Zurich’s ‘Accelerate’ Alleviate NHS Pressure? A Deep Dive into the New Medical Service

2 Comments

1. 

   david berry on 1st June 2024 at 2:37 pm

   it is clear that Accelerate will be more useful covering heart surgery conditions which are invasive and neurology
   waiting lists for these being much longer. typical chemotherapy can take between 4 and 6 months so nearly all patients will not go down the overseas route anyway.
   what will be more interesting is a direct comparison from Protection Guru of the differences between this and Aviva op
   All insurers should advertise surgery for Cancer conditions and for the life of me cannot understand why Royal London and Guardian are the only providers who payout for PROSTATE cancer as additional condition on diagnosis when this can take several years before it reaches surgery stage Well done to them ) well done to Legal and General having what Zurich have the initial stages for just £4.50 month. Aviva of course only reviewed every 3 years Zurich open ended from start
   the ultimate a new product hybrid with some private medical care included
   the first to do this will deserve all the Business absolutely certain about that.

   Reply
2. 

   david berry on 5th June 2024 at 1:39 pm

   you make the comment about heart surgery diagnosis of urgent case on nhs aim for 2 weeks and diagnostic teats 6 weeks then Aviva available for global treatment through further also legal and general have have diagnostic tests at £4.50 per month
   and Zurich can give 3 months notice about any change in costs Aviva every 3 years nothing special here . also mention introductory cost.
   Aviva have identified other loopholes in cover suggest you look into more closely

   Reply